Moffitt at SITC

T Cells Attacking Tumor

Moffitt Cancer Center’s research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances. As pioneers of immunotherapy as a groundbreaking cancer treatment, we were excited to participate in the Society for Immunotherapy of Cancer Annual Meeting from November 8-12. The studies our scientists presented explored many advances in areas like radiomics, checkpoint inhibitors and TIL therapy covering many cancer types.

To learn more about Moffitt's research and breakthroughs, follow Moffitt on Twitter (@MoffittNews) and LinkedIn or subscribe to our newsletters.

Moffitt at SITC

2022 Featured Articles

Cellular Therapy May Be Viable Option for Advanced Melanoma Patients
Nearly one-third of patients respond to a single infusion of tumor infiltrating lymphocytes.

Using AI to Dictate Treatment for Non-Small Cell Lung Cancer
Data presented at the Society for Immunotherapy of Cancer shows AI can perform biomarker tests.

New Immunotherapy Could Be on the Horizon for Ovarian Cancer
Understanding tertiary lymphoid structures could unlock new treatments for a variety of cancers.

Phase 2 Bladder Cancer Trial Shows Promising Results
Updated data were presented at the 2022 SITC Annual Meeting.

Media Contact:

For additional information on Moffitt’s research presented at SITC please reach out to:

Photo of Kim Polacek
Kim Polacek, APR, CPRC
Senior PR Account Coordinator
Email

 

Videos


 

Moffitt Resources

cells

Office of Innovation and Industry Alliances

Forging partnerships with startups and industry to bring cutting edge ideas and discovers to the marketplace.

Researchers in a lab

Science & Research Careers

Our researchers drive cutting-edge discoveries that are rapidly translated into improved diagnostic, preventive and therapeutic advances.

A group of African American at a meeting

Diversity, Equity and Inclusion

The diversity of our employees and communities is valued and supported as essential components to contributing to the prevention and cure of cancer.

Cancer Cells

Clinical Trials

With our robust portfolio of clinical trials, Moffitt remains firmly established at the forefront of cancer research.

Cell Therapies Lab

Cell Therapies Core

The Cell Therapies Core provides service to members to facilitate translation of promising therapies for cancer patients.

Physician liaison meeting with doctors

Physician Liaison Team

Our goal is to forge partnerships with healthcare professionals to improve patient access and outcomes.